ask="1.52"
ask_size="2000"
average_daily_volume="340298"
bid="1.40"
bid_size="4600"
book_value="0.51"
change="-0.08"
change_from_200_day_moving_average="0.18"
change_from_50_day_moving_average="-0.02"
change_from_52_week_high="-1.44"
change_From_52_week_low="0.55"
change_in_percent="-5.23%"
close="1.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.29"
ebitda="0.00"
eps_estimate_current_year="-0.98"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-1.00"
ex_dividend_date="N/A"
float_shares="12508000"
high="1.56"
high_52_weeks="2.89"
last_trade_date="3/2/2017"
last_trade_price="1.45"
last_trade_size="300"
last_trade_time="3:59pm"
low="1.43"
low_52_weeks="0.90"
market_capitalization="29.25M"
moving_average_200_day="1.27"
moving_average_50_day="1.47"
name="Viking Therapeutics
Inc."
notes="N/A"
one_year_target_price="7.56"
open="1.53"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="+14.22%"
percent_change_from_50_day_moving_average="-1.37%"
percent_change_from_52_week_high="-49.83%"
percent_change_from_52_week_low="+60.93%"
previous_close="1.53"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.98"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="20170000"
short_ratio="1.57"
stock_exchange="NCM"
symbol="VKTX"
volume="243610"
weeks_range_52="0.90 - 2.89"
